Can your home air trigger asthma? new study investigates
NCT ID NCT05525169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 30 adults with asthma to see if changes in indoor and outdoor air pollution are linked to asthma attacks. Participants will have sensors placed in their homes to measure pollutants like fine particles and chemicals. The goal is to understand which pollutants are most harmful and help guide future prevention strategies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2022
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of adult men and women recruited from the active file of asthma patients followed at the Nantes University Hospital, the Saint Nazaire Hospital, the Châteaubriant Nozay Pouancé Hospital and the Erdre et Loire Hospital. Regardless of the type of asthma, patients will be potentially included if they have a minimum of 4 exacerbations during the year preceding inclusion in the EXAP project\>. Participation in other non-interventional research is allowed during the study unless this research increases the number of exacerbations.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient over 18 years of age, * Patient with a confirmed diagnosis of asthma for at least 12 months as defined by the investigator, * Patient with at least 4 asthma exacerbations in the last year * Patient sleeping at least 6 nights per week in the same home Exclusion Criteria: * Patient who is an active smoker or living with an active smoker, * Patient with a diagnosis of COPD, ABPA or associated pulmonary fibrosis, * Patient with an asthma exacerbation within 15 days prior to the inclusion visit, * Patient with known occupational exposure, * Patient living in a dwelling that does not allow the installation of sensors (inability to connect the sensor to the power supply, no location for the outdoor sensor...) * Patient who plans to move in the next 6 months, * Patient with a life expectancy of less than 6 months, * Patient who has someone living in their household also included in EXAP, * Patient who lives in an apartment and does not have a balcony or space for the outdoor sensor, * Pregnant or breastfeeding women,
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Nantes
RECRUITINGNantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single triple inhaler tame asthma in the real world?
- Can a Three-Drug inhaler outperform the standard Two-Drug treatment for asthma?
- Can a new inhaler match Symbicort's performance?
- Fine-Mist inhalers aim to reach deep lungs in COPD
- Can a hormone supplement tame asthma?
- A wearable stethoscope may let kids with asthma monitor their lungs at home